UNSPSC 51143301: Phenobarbital/phenytoin

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CN400. This VA Drug Class (CN400) classifies this compound as belonging to the group ANTICONVULSANTS.

UNSPSC 51143301 Phenobarbital/phenytoin is a Commodity code that captures pharmaceutical products procured by state and local health agencies, though the recent solicitations tagged under this code show little direct activity specifically for this anticonvulsant medication. Instead, state and local buyers are using related pharmaceutical procurement vehicles to source a broader range of prescription and over-the-counter drugs through cooperative purchasing and direct-distribution models. Issuing bodies include county health departments (Seminole County, Florida), state health and human services commissions (Texas Health and Human Services Commission), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, or MMCAP). These jurisdictions procure pharmaceuticals to support community health initiatives, employee health plans, and statewide distribution networks, typically requiring compliance with FDA manufacturing standards, Drug Supply Chain Security Act certification, and current Good Manufacturing Practices.

Recent procurement activity spans Florida, Texas, and Minnesota. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026 (due July 26, 2023) to procure naloxone and drug deactivation systems for quarterly delivery to the Seminole County Community Health Building—a two-year contract with one-year renewal option. The Texas Health and Human Services Commission posted RFI HHS0017013 on April 3, 2026 to gather vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program, seeking information about direct contracting between state pharmacy benefit programs and pharmaceutical manufacturers outside traditional pharmacy benefit manager arrangements. The Minnesota Department of Administration, administering MMCAP, issued RFP S1070000015802 on January 20, 2026 (due March 26, 2026) for generic multi-source pharmaceuticals and OTC products for distribution across Minnesota, Oregon, and other participating jurisdictions through authorized wholesalers including AmerisourceBergen Drug Corporation, Cardinal Health, and Morris & Dickson Co., LLC, with contracts effective July 1, 2026.